Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)
Clinical trial NCT02518672 · TERMINATED
Trial details
- NCT number
- NCT02518672
- Sponsor
- SCF Pharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-03-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.